Get the Stockscreener App
9.14
0.33%
-0.03
After Hours:
9.13
-0.010
-0.11%
Optinose Inc Stock (OPTN) Latest News
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights - GlobeNewswire
OPTINOSE Earnings Results: $OPTN Reports Quarterly Earnings - Nasdaq
OptiNose: Q4 Earnings Snapshot - erienewsnow.com
OptiNose Q4 Net Loss Narrows - Nasdaq
OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
OptiNose Q4 Income From Operations USD 354 Thousand - Marketscreener.com
OptiNose Inc. Q4 Loss Decreases, Beats Estimates - Nasdaq
Wall Street Analysts Believe OptiNose (OPTN) Could Rally 143.06%: Here's is How to Trade - Yahoo Finance
Paratek Pharmaceuticals’ Acquisition of Optinose - Global Legal Chronicle
Piper Sandler Reaffirms Neutral Rating for OptiNose (NASDAQ:OPTN) - Defense World
HC Wainwright Reaffirms Neutral Rating for OptiNose (NASDAQ:OPTN) - Defense World
OptiNose (NASDAQ:OPTN) Cut to “Hold” at Piper Sandler - Defense World
OptiNose (NASDAQ:OPTN) Rating Lowered to “Hold” at Lake Street Capital - Defense World
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc.OPTN - Business Wire
Earnings To Watch: OptiNose Inc (OPTN) Reports Q4 2024 Result - GuruFocus.com
OPTN Stock Soars 53% on Inking $330M Deal to be Acquired by Paratek - MSN
Paratek Pharmaceuticals Acquires Yardley-Based Optinose in $330M Deal - BUCKSCO.Today
This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
Further Upside For OptiNose, Inc. (NASDAQ:OPTN) Shares Could Introduce Price Risks After 56% Bounce - Simply Wall St
Why OptiNose Inc. (OPTN) Surged On Thursday? - Insider Monkey
ProAssurance (PRA) and Optinose (OPTN) soar on M&A news - InvestorsObserver
Darden Restaurants, Nike, Optinose - TradingView
10 Micro-, Small-Cap Firms Dominate Thursday’s Gains - Insider Monkey
Lake Street cuts Optinose stock rating, lowers target to $9 By Investing.com - Investing.com Australia
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of OptiNose, Inc.OPTN - The Malaysian Reserve
Paratek To Acquire Optinose, Expanding Portfolio Beyond Antibiotics - News & Insights
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, BECN, OPTN on Behalf of Shareholders - The Malaysian Reserve
Sector Update: Health Care Stocks Mixed in Afternoon Trading -March 20, 2025 at 02:03 pm EDT - Marketscreener.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Optinose Shares Soar After Merger Agreement With Paratek Pharmaceuticals: Retail Sentiment Takes Flight - MSN
Optinose to be acquired by Boston-based Paratek Pharmaceuticals in potential $330M deal - The Business Journals
Piper Sandler Downgrades OptiNose to Neutral From Overweight, $9 Price Target -March 20, 2025 at 12:32 pm EDT - Marketscreener.com
Paratek to buy Optinose for up to $330 million - The Pharma Letter
Lake Street cuts Optinose stock rating, lowers target to $9 - Investing.com
Paratek Broadens Portfolio With OptiNose Buy Worth up to $330M - BioSpace
Hold Rating Issued Amid Optinose Acquisition by Paratek Pharmaceuticals with Adjusted Price Target - TipRanks
OPTN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Optinose, Inc. Is Fair to Shareholders - Eagle-Tribune
OptiNose Stock Is Soaring Today: What's Going On? - Benzinga India
Sector Update: Health Care Stocks Decline Pre-Bell Thursday -March 20, 2025 at 09:20 am EDT - Marketscreener.com
Shareholder Alert: The Ademi Firm investigates whether Optinose, Inc. is obtaining a Fair Price for its Public Shareholders - Business Wire
OptiNose stock climbs on M&A deal with Paratek (OPTN:NASDAQ) - Seeking Alpha
OptiNose Surges Premarket Following Acquisition Agreement With Paratek Pharmaceuticals for Up to $330 Million - Marketscreener.com
Why Five Below Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Optinose Shares Surge Premarket on Takeover Deal With Paratek - MarketWatch
Optinose Stock: Paratek Acquires Firm for $330M - Sharewise
Paratek to acquire Optinose for up to $330 million By Investing.com - Investing.com South Africa
Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call - GlobeNewswire
Paratek Pharmaceuticals to Acquire Optinose - citybiz
Paratek Acquisition Prompts Optinose to Skip Q4 Earnings CallWhat's Next for Investors - StockTitan
Optinose Cancels Earnings Conference Call Following Acquisition Agreement with Paratek Pharmaceuticals - Nasdaq
Optinose CEO Mahmoud Ramy A sells $2,064 in common stock By Investing.com - Investing.com South Africa
Paratek Pharmaceuticals To Acquire Optinose for Up To $330 Million -March 19, 2025 at 09:29 pm EDT - Marketscreener.com
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS) - The Manila Times
Paratek to acquire Optinose for up to $330 million - Investing.com India
Optinose chief legal officer sells shares worth $1,380 By Investing.com - Investing.com South Africa
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS) - Benzinga
2.46%
0.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):